These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 11703219

  • 1. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma.
    Mita H, Endoh S, Kudoh M, Kawagishi Y, Kobayashi M, Taniguchi M, Akiyama K.
    Allergy; 2001 Nov; 56(11):1061-7. PubMed ID: 11703219
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma.
    Sladek K, Szczeklik A.
    Eur Respir J; 1993 Mar; 6(3):391-9. PubMed ID: 8386106
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis.
    Ono E, Taniguchi M, Mita H, Fukutomi Y, Higashi N, Miyazaki E, Kumamoto T, Akiyama K.
    Clin Exp Allergy; 2009 Jan; 39(1):72-80. PubMed ID: 19128354
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics.
    Kumlin M, Dahlén B, Björck T, Zetterström O, Granström E, Dahlén SE.
    Am Rev Respir Dis; 1992 Jul; 146(1):96-103. PubMed ID: 1320824
    [Abstract] [Full Text] [Related]

  • 10. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients.
    Obase Y, Shimoda T, Tomari SY, Mitsuta K, Kawano T, Matsuse H, Kohno S.
    Chest; 2002 Jan; 121(1):143-50. PubMed ID: 11796443
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction.
    O'Sullivan S, Dahlén B, Dahlén SE, Kumlin M.
    J Allergy Clin Immunol; 1996 Aug; 98(2):421-32. PubMed ID: 8757220
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics.
    Micheletto C, Tognella S, Visconti M, Trevisan F, Dal Negro RW.
    Respir Med; 2006 Dec; 100(12):2144-50. PubMed ID: 16678396
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma.
    Yoshida S, Amayasu H, Sakamoto H, Onuma K, Shoji T, Nakagawa H, Tajima T.
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):171-6. PubMed ID: 9494450
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma.
    Higashi N, Taniguchi M, Mita H, Osame M, Akiyama K.
    Clin Exp Allergy; 2002 Oct; 32(10):1484-90. PubMed ID: 12372129
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma.
    Sestini P, Armetti L, Gambaro G, Pieroni MG, Refini RM, Sala A, Vaghi A, Folco GC, Bianco S, Robuschi M.
    Am J Respir Crit Care Med; 1996 Feb; 153(2):572-5. PubMed ID: 8564100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.